10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY  REPORT PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934

For the quarterly period ended September 30, 2013.

OR

[  ] TRANSITION REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934

For the transition period from to.

Commission File Number   1-12273

ROPER INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)	51-0263969 (I.R.S. Employer Identification No.)
6901 Professional Pkwy. East, Suite 200Sarasota, Florida(Address of principal executive offices)	34240 (Zip Code)
(941) 556-2601 (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  þ Yes ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  þ Yes ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

þ Large accelerated filer	¨ Accelerated filer
¨ Non-accelerated filer (do not check if smaller reporting company)	¨ Smaller reporting company

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes þ No

The number of shares outstanding of the Registrant's common stock as of November 1, 2013 was 99,309,540.

ROPER INDUSTRIES, INC.

REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited):
	Condensed Consolidated Statements of Earnings	3
	Condensed Consolidated Statements of Comprehensive Income	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Cash Flows	6
	Condensed Consolidated Statement of Changes in Stockholders' Equity	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 6.	Exhibits	23
	Signatures	24

PART I. FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Earnings (unaudited)

(in thousands, except per share data)

	Three months ended September 30,					Nine months ended September 30,
	2013		2012			2013		2012
Net sales	$	827,810	$	747,641		$	2,348,955	$	2,183,579
Cost of sales		345,185		331,086			999,247		978,223
Gross profit		482,625		416,555			1,349,708		1,205,356
Selling, general and administrative expenses		263,276		233,298			765,436		673,011
Income from operations		219,349		183,257			584,272		532,345
Interest expense		24,705		16,456			67,924		47,016
Loss on extinguishment of debt		-		1,043			-		1,043
Other income/(expense), net		409		(1,380	)		453		(2,444	)
Earnings before income taxes		195,053		164,378			516,801		481,842
Income taxes		58,730		47,670			144,211		142,012
Net earnings	$	136,323	$	116,708		$	372,590	$	339,830
Net earnings per share:
Basic	$	1.37	$	1.19		$	3.76	$	3.49
Diluted		1.36		1.17			3.72		3.41
Weighted average common shares outstanding:
Basic		99,207		97,876			99,058		97,460
Diluted		100,302		99,757			100,152		99,543
Dividends declared per common share	$	0.1650	$	0.1375		$	0.4950	$	0.4125

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (unaudited)

(in thousands)

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013			2012
Net earnings	$	136,323	$	116,708	$	372,590		$	339,830
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustments		31,902		36,395		(10,219	)		22,348
Total other comprehensive income/(loss), net of tax		31,902		36,395		(10,219	)		22,348
Comprehensive income	$	168,225	$	153,103	$	362,371		$	362,178

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (unaudited)

(in thousands)

	September 30, 2013			December 31, 2012
ASSETS:
Cash and cash equivalents	$	459,980		$	370,590
Accounts receivable, net		505,284			526,408
Inventories, net		204,722			190,867
Deferred taxes		88,421			41,992
Unbilled receivables		85,375			72,193
Other current assets		45,417			43,492
Total current assets		1,389,199			1,245,542
Property, plant and equipment, net		117,785			110,397
Goodwill		4,541,772			3,868,857
Other intangible assets, net		2,051,685			1,698,867
Deferred taxes		68,048			78,644
Other assets		77,086			68,797
Total assets	$	8,245,575		$	7,071,104
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable	$	142,987		$	138,340
Accrued compensation		100,901			110,724
Deferred revenue		212,275			185,912
Other accrued liabilities		153,293			128,351
Deferred taxes		12,431			3,868
Current portion of long-term debt, net		12,250			519,015
Total current liabilities		634,137			1,086,210
Long-term debt, net of current portion		2,593,607			1,503,107
Deferred taxes		862,986			707,278
Other liabilities		92,032			86,783
Total liabilities		4,182,762			3,383,378
Commitments and contingencies (Note 10)
Common stock		1,013			1,006
Additional paid-in capital		1,219,648			1,158,001
Retained earnings		2,813,356			2,489,858
Accumulated other comprehensive earnings		48,318			58,537
Treasury stock		(19,522	)		(19,676	)
Total stockholders' equity		4,062,813			3,687,726
Total liabilities and stockholders' equity	$	8,245,575		$	7,071,104

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (unaudited)

(in thousands)

	Nine months ended September 30,
	2013			2012
Cash flows from operating activities:
Net earnings	$	372,590		$	339,830
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment		28,269			28,402
Amortization of intangible assets		111,210			82,398
Amortization of deferred financing costs		2,916			1,750
Non-cash stock compensation		40,040			30,143
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable		43,101			6,685
Unbilled receivables		(13,257	)		(2,698	)
Inventories		(15,202	)		(2,985	)
Accounts payable and accrued liabilities		13,055			(8,617	)
Income taxes		(12,643	)		(14,258	)
Other, net		(3,306	)		5,564
Cash provided by operating activities		566,773			466,214
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		(1,014,952	)		(1,445,549	)
Capital expenditures		(33,349	)		(29,236	)
Proceeds from sale of assets		1,740			1,196
Other, net		(144	)		(542	)
Cash used in investing activities		(1,046,705	)		(1,474,131	)
Cash flows from financing activities:
Proceeds from senior notes		800,000			-
Payment of senior notes		(500,000	)		-
Borrowings/(payments) under revolving line of credit, net		290,000			1,050,000
Principal payments on convertible notes		(2,115	)		(26,826	)
Cash premiums paid on convertible note conversions		(5,100	)		(19,149	)
Debt issuance costs		(7,717	)		(4,551	)
Cash dividends to stockholders		(32,706	)		(40,102	)
Proceeds from stock based compensation, net		16,839			40,105
Stock award tax excess windfall benefit		7,763			19,873
Treasury stock sales		1,833			1,623
Other		723			(979	)
Cash provided by financing activities		569,520			1,019,994
Effect of foreign currency exchange rate changes on cash		(198	)		4,931
Net increase in cash and cash equivalents		89,390			17,008
Cash and cash equivalents, beginning of period		370,590			338,101
Cash and cash equivalents, end of period	$	459,980		$	355,109

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

(in thousands)

	Common stock		Additional paid-in capital			Retained earnings			Accumulated other comprehensive earnings			Treasury stock			Total
Balances at December 31, 2012	$	1,006	$	1,158,001		$	2,489,858		$	58,537		$	(19,676	)	$	3,687,726
Net earnings		-		-			372,590			-			-			372,590
Stock option exercises		4		20,446			-			-			-			20,450
Treasury stock sold		-		1,679			-			-			154			1,833
Currency translation adjustments, net of $889 tax		-		-			-			(10,219	)		-			(10,219	)
Stock based compensation		-		40,201			-			-			-			40,201
Restricted stock activity		3		(3,598	)		-			-			-			(3,595	)
Stock option tax benefit, net of shortfalls		-		7,632			-			-			-			7,632
Conversion of senior subordinated convertible notes, net of $386 tax				(4,713	)		-			-			-			(4,713	)
Dividends declared		-		-			(49,092	)		-			-			(49,092	)
Balances at September 30, 2013	$	1,013	$	1,219,648		$	2,813,356		$	48,318		$	(19,522	)	$	4,062,813

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

September 30, 2013

1. Basis of Presentation

The accompanying condensed consolidated financial statements for the three and nine month periods ended September 30, 2013 and 2012 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2012 financial position data included herein was derived from the audited consolidated financial statements included in the 2012 Annual Report on Form 10-K ("Annual Report") filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.

2. Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In July 2012, the FASB issued an amendment to accounting rules related to the testing of indefinite-lived intangibles.  The new accounting rules permit an entity to first assess qualitative factors to determine if it is more likely than not that an indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test prescribed under current accounting rules.   Roper adopted this guidance on January 1, 2013.  The guidance did not have an impact on the Company's results of operations, financial position or cash flows.

3. Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Basic shares outstanding		99,207		97,876		99,058		97,460
Effect of potential common stock:
Common stock awards		905		1,017		894		1,077
Senior subordinated convertible notes		190		864		200		1,006
Diluted shares outstanding		100,302		99,757		100,152		99,543

For the three and nine month periods ended September 30, 2013 there were 551,850 and 601,350 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive; this compares to 540,266 and 589,666 outstanding stock options, respectively, that would have been antidilutive for the three and nine month periods ended September 30, 2012.

4. Business Acquisitions

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction.  MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform.  MHA is reported in the Medical & Scientific Imaging segment.

During the nine month period ended September 30, 2013, the Company expensed transaction costs of $2.5 million related to the acquisition as corporate general and administrative expenses, as incurred.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.  The allocation of the purchase price is considered preliminary pending tax-related adjustments.  Pro forma data has not been provided as the acquisition of MHA was not material to the Company's operations.

Current assets	$         59,813
Identifiable intangibles	465,500
Goodwill	680,732
Other assets	5,798
Total assets acquired	1,211,843
Current liabilities	(24,717	)
Long-term deferred tax liability	(165,052	)
Other liabilities	(6,524	)
Net assets acquired	$    1,015,550

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable at the date of acquisition. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue-share obligation owed to customers that generated the administrative fees.  Both of these fair value adjustments were fully amortized as of September 30, 2013.

The majority of the goodwill is not expected to be deductible for tax purposes.  Of the $466 million of intangible assets acquired, $28 million was assigned to trade names that are not subject to amortization. The remaining $438 million of acquired intangible assets have a weighted-average useful life of approximately 20 years. The intangible assets that make up that amount include customer relationships of $433 million (20 year weighted-average useful life) and technology of $5 million (3 year weighted-average useful life).

On August 22, 2012, Roper acquired 100% of the shares of Sunquest Information Systems, Inc. ("Sunquest").  Roper's results for the quarter ended September 30, 2012 included results from Sunquest between August 22, 2012 and September 30, 2012.  In that period, Sunquest contributed $21.0 million in revenue and $0.2 million of earnings (inclusive of deal-related costs) to Roper's results.  The following unaudited pro forma summary presents consolidated information as if the acquisition of Sunquest had occurred on January 1, 2011.  This supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition of Sunquest been completed on January 1, 2011, nor is it indicative of any future results. Amounts shown are in thousands, except per share data:

	Three months ended September 30, 2012		Nine months ended September 30, 2012
Sales	$	780,278	$	2,320,497
Net income		128,226		380,046
Earnings per share, basic		1.31		3.90
Earnings per share, diluted		1.29		3.82

Pro forma earnings for the three and nine months ended September 30, 2012 were adjusted by $41.3 million and $50.6 million, respectively, for non-recurring acquisition and other costs as well as recurring changes in amortization, interest expense and taxes related to the acquisition.

5. Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan (the "Plan") is a stock based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. The common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock based compensation expense (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Stock based compensation	$	13,756	$	10,439	$	40,040	$	30,143
Tax effect recognized in net income		4,814		3,654		14,014		10,550
Windfall tax benefit, net		2,075		9,009		7,632		19,975

Stock Options - In the nine month period ended September 30, 2013, 560,350 options were granted with a weighted average fair value of $36.87 per option. During the same period in 2012, 531,100 options were granted with a weighted average fair value of $30.19 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data, among other factors, is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year periods using the Black-Scholes option-pricing model:

	Nine months ended September 30,
	2013	2012
Fair value per share ($)	36.87	30.19
Risk-free interest rate (%)	0.80	0.77
Expected option life (years)	5.19	5.24
Expected volatility (%)	36.20	36.51
Expected dividend yield (%)	0.57	0.58

Cash received from option exercises for the nine months ended September 30, 2013 and 2012 was $20.5 million and $40.1 million, respectively.

Restricted Stock Awards - During the nine months ended September 30, 2013, 357,240 restricted stock awards were granted with a weighted average fair value of $116.76 per restricted share. During the same period in 2012, 358,807 awards were granted with a weighted average fair value of $95.10 per restricted share. All grants were issued at grant date fair value.

During the nine months ended September 30, 2013, 123,762 restricted awards vested with a weighted average grant date fair value of $63.65 per restricted share, at a weighted average vest date fair value of $120.92 per restricted share.

Employee Stock Purchase Plan - During the nine month periods ended September 30, 2013 and 2012, participants of the employee stock purchase plan purchased 15,458 and 17,410 shares, respectively, of Roper's common stock for total consideration of $1.8 million and $1.6 million, respectively. All shares were purchased from Roper's treasury shares.

6. Inventories

The components of inventories at September 30, 2013 and December 31, 2012 were as follows (in thousands)

	September 30, 2013			December 31, 2012
Raw materials and supplies	$	128,809		$	121,573
Work in process		33,133			29,725
Finished products		88,614			81,536
Inventory reserves		(45,834	)		(41,967	)
	$	204,722		$	190,867

7. Goodwill and Other Intangible Assets

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology		Energy Systems & Controls			Medical & Scientific  Imaging			RF Technology			Total
Balances at December 31, 2012	$	421,755	$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-		-			680,732			-			680,732
Other		-		2,660			(4,283	)		445			(1,178	)
Currency translation adjustments		1,929		(215	)		(7,084	)		(1,269	)		(6,639	)
Balances at September 30, 2013	$	423,684	$	406,502		$	2,441,767		$	1,269,819		$	4,541,772

Other intangible assets are comprised of (in thousands):

	Cost		Accumulated amortization			Net book value
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,939,270	$	(456,068	)	$	1,483,202
Unpatented technology		212,049		(116,355	)		95,694
Software		160,496		(54,777	)		105,719
Patents and other protective rights		30,390		(22,017	)		8,373
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		358,697		-			358,697
Balances at September 30, 2013	$	2,702,402	$	(650,717	)	$	2,051,685

Amortization expense of other intangible assets was $108,223 and $79,335 during the nine months ended September 30, 2013 and 2012, respectively.

8. Debt

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018.  The notes were issued at 99.791% of their principal amount.  The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility.

The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness.  The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness.  The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.

On August 15, 2013, $500 million of senior notes matured, and were repaid using borrowings from the Company's $1.5 billion revolving credit facility.

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the nine month period ended September 30, 2013, 4,471 notes were converted for $7.1 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.4 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At September 30, 2013, the conversion price on the outstanding notes was $470.55.  If converted at September 30, 2013, the value would exceed the $10 million principal amount of the notes by approximately $25 million and could result in the issuance of 190,306 shares of Roper's common stock.

9. Fair Value of Financial Instruments

Roper's debt at September 30, 2013 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million senior notes due 2017	$  398
$800 million senior notes due 2018	786
$500 million senior notes due 2019	583
$500 million senior notes due 2022	468

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $10 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

On August 15, 2013, an aggregate notional amount of $500 million in interest rate swaps expired.  The swaps had been designated as fair value hedges which had effectively changed Roper's $500 million senior notes due 2013 with a fixed interest rate of 6.625% to a variable-rate obligation at a weighted average spread of 4.377% plus the 3 month London Interbank Offered Rate ("LIBOR").

10. Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. The Company is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the nine months ended September 30, 2013 is presented below (in thousands):

Balance at December 31, 2012	$	9,755
Additions charged to costs and expenses*		17,659
Deductions		(11,251	)
Other		(168)
Balance at September 30, 2013	$	15,995

* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.

11. Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three months ended September 30,						Nine months ended September 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	200,684	$	199,008	0.8	%	$	580,466	$	598,088	(2.9	)%
Energy Systems & Controls		155,058		158,169	(2.0	)		456,031		461,508	(1.2	)
Medical & Scientific Imaging		237,338		172,475	37.6			645,739		486,207	32.8
RF Technology		234,730		217,989	7.7			666,719		637,776	4.5
Total	$	827,810	$	747,641	10.7	%	$	2,348,955	$	2,183,579	7.6	%
Gross profit:
Industrial Technology	$	101,259	$	102,569	(1.3	)%	$	296,414	$	304,002	(2.5	)%
Energy Systems & Controls		88,104		87,782	0.4			256,431		254,325	0.8
Medical & Scientific Imaging		167,433		112,013	49.5			440,718		314,411	40.2
RF Technology		125,829		114,191	10.2			356,145		332,618	7.1
Total	$	482,625	$	416,555	15.9	%	$	1,349,708	$	1,205,356	12.0	%
Operating profit*:
Industrial Technology	$	60,753	$	60,628	0.2	%	$	164,278	$	180,211	(8.8	)%
Energy Systems & Controls		41,076		42,890	(4.2	)		118,432		118,749	(0.3	)
Medical & Scientific Imaging		71,968		46,190	55.8			179,433		125,231	43.3
RF Technology		66,469		58,002	14.6			183,828		166,516	10.4
Total	$	240,266	$	207,710	15.7	%	$	645,971	$	590,707	9.4	%
Long-lived assets:
Industrial Technology	$	49,055	$	42,970
Energy Systems & Controls		19,501		19,016
Medical & Scientific Imaging		43,105		44,784
RF Technology		28,360		29,230
Total	$	140,021	$	136,000

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,917 and $24,453 for the three months ended September 30, 2013 and 2012, respectively, and $61,699 and $58,362 for the nine months ended September 30, 2013 and 2012, respectively.

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report for the year ended December 31, 2012 as filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.

Information About Forward-Looking Statements

This report includes "forward-looking statements" within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the SEC or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are "forward-looking statements."  Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.

Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our internal operating plans, our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:

· general economic conditions;

· difficulty making acquisitions and successfully integrating acquired businesses;

· any unforeseen liabilities associated with future acquisitions;

· limitations on our business imposed by our indebtedness;

· unfavorable changes in foreign exchange rates;

· difficulties associated with exports;

· risks and costs associated with our international sales and operations;

· increased directors' and officers' liability and other insurance costs;

· risk of rising interest rates;

· product liability and insurance risks;

· increased warranty exposure;

· future competition;

· the cyclical nature of some of our markets;

· reduction of business with large customers;

· risks associated with government contracts;

· changes in the supply of, or price for, raw materials, parts and components;

· environmental compliance costs and liabilities;

· risks and costs associated with asbestos-related litigation;

· potential write-offs of our substantial goodwill and other intangible assets;

· our ability to successfully develop new products;

· failure to protect our intellectual property;

· the effect of, or change in, government regulations (including tax);

· economic disruption caused by terrorist attacks, health crises or other unforeseen events; and

· the factors discussed in other reports filed with the SEC.

We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.

Overview

Roper Industries, Inc. ("Roper," "we" or "us") is a diversified growth company that designs, manufactures and distributes radio frequency ("RF") products, services and application software, industrial technology products, energy systems and controls and medical and scientific imaging products and software. We market these products and services to a broad range of markets, including RF applications, medical, water, energy, research, education, software-as-a-service ("SaaS")-based information networks, security and other niche markets.

We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses that offer high value-added services, engineered products and solutions and are capable of achieving growth and maintaining high margins. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our investments.

Critical Accounting Policies

There were no material changes during the three or nine month periods ended September 30, 2013 to the items that we disclosed as our critical accounting policies and estimates in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2012 Annual Report on Form 10-K filed on February 25, 2013.

Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the notes to Condensed Consolidated Financial Statements.

Results of Operations

General

The following tables set forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of net sales. Percentages may not foot due to rounding.

	Three months ended September 30,						Nine months ended September 30,
	2013			2012			2013			2012
Net sales:
Industrial Technology	$	200,684		$	199,008		$	580,466		$	598,088
Energy Systems & Controls		155,058			158,169			456,031			461,508
Medical & Scientific Imaging		237,338			172,475			645,739			486,207
RF Technology		234,730			217,989			666,719			637,776
Total	$	827,810		$	747,641		$	2,348,955		$	2,183,579
Gross profit:
Industrial Technology		50.5	%		51.5	%		51.1	%		50.8	%
Energy Systems & Controls		56.8			55.5			56.2			55.1
Medical & Scientific Imaging		70.5			64.9			68.3			64.7
RF Technology		53.6			52.4			53.4			52.2
Total		58.3			55.7			57.5			55.2
Selling, general & administrative expenses:
Industrial Technology		20.2	%		21.1	%		22.8	%		20.7	%
Energy Systems & Controls		30.3			28.4			30.3			29.4
Medical & Scientific Imaging		40.2			38.2			40.5			38.9
RF Technology		25.3			25.8			25.8			26.0
Total		29.3			27.9			30.0			28.1
Segment operating profit:
Industrial Technology		30.3	%		30.5	%		28.3	%		30.1	%
Energy Systems & Controls		26.5			27.1			26.0			25.7
Medical & Scientific Imaging		30.3			26.8			27.8			25.8
RF Technology		28.3			26.6			27.6			26.1
Total		29.0			27.8			27.5			27.1
Corporate administrative expenses		(2.5	)		(3.3	)		(2.6	)		(2.7	)
		26.5			24.5			24.9			24.4
Interest expense		(3.0	)		(2.2	)		(2.9	)		(2.2	)
Other income/(expense)		-			(0.3	)		-			(0.2	)
Earnings before income taxes		23.6			22.0			22.0			22.1
Income taxes		(7.1	)		(6.4	)		(6.1	)		(6.5	)
Net earnings		16.5	%		15.6	%		15.9	%		15.6	%

Three months ended September 30, 2013 compared to three months ended September 30, 2012

Net sales for the quarter ended September 30, 2013were $827.8 million as compared to $747.6 million in the prior year quarter, an increase of 11%. The increase was the result of organic growth of 3% and an 8% increase in sales from acquisitions.

In our Industrial Technology segment, net sales were up 1% to $200.7 million in the third quarter of 2013 as compared to $199.0 million in the third quarter of 2012 due to increased sales in our fluid handling businesses.  Gross margins decreased to 50.5% in the third quarter of 2013 as compared to 51.5% in the third quarter of 2012 due to product mix. Selling, general and administrative ("SG&A") expenses as a percentage of net sales were 20.2% in the third quarter of 2013, compared to 21.1% in the prior year quarter due to product mix. The resulting operating profit margins were 30.3% in the third quarter of 2013 as compared to 30.5% in the third quarter of 2012.

Net sales in our Energy Systems & Controls segment decreased by 2% to $155.1 million during the third quarter of 2013 compared to $158.2 million in the third quarter of 2012, due to decreased demand in nuclear plant inspection end markets offset in part by increased demand for control systems for oil and gas applications.  Gross margins increased to 56.8% in the third quarter of 2013 compared to 55.5% in the third quarter of 2012 due to product mix. SG&A expenses as a percentage of net sales were 30.3% in the third quarter of 2013, compared to 28.4% in the prior year quarter due to negative operating leverage on lower sales volume. As a result, operating margins were 26.5% in the third quarter of 2013 as compared to 27.1% in the third quarter of 2012.

In our Medical & Scientific Imaging segment, net sales increased by 38% to $237.3 million in the third quarter of 2013 as compared to $172.5 million in the third quarter of 2012. The change was comprised of a 35% increase from acquisitions, organic growth of 3%, and a small negative impact from foreign exchange.  We experienced continued growth in our medical businesses, offset in part by weakness in camera sales into research markets.  Gross margins increased to 70.5% in the third quarter of 2013 from 64.9% in the third quarter of 2012 due to the higher gross margin profile of our acquired businesses. SG&A expenses as a percentage of net sales increased to 40.2% in the third quarter of 2013 as compared to 38.2% in the third quarter of 2012 due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements). As a result, operating margins were 30.3% in the third quarter of 2013 as compared to 26.8% in the third quarter of 2012.

In our RF Technology segment, net sales were $234.7 million in the third quarter of 2013 as compared to $218.0 million in the third quarter of 2012, an increase of 8%.  The increase was due primarily to growth in our toll and traffic and university card systems businesses. Gross margins increased to 53.6% in the third quarter of 2013, as compared to 52.4% in the prior year quarter due to a more favorable mix between products and software in the current year quarter. SG&A expenses as a percentage of net sales in the third quarter of 2013 were 25.3% as compared to 25.8% in the prior year. As a result, operating profit margins were 28.3% in the third quarter of 2013 as compared to 26.6% in the third quarter of 2012.

Corporate expenses were $20.9 million, or 2.5% of net sales, in the third quarter of 2013 as compared to $24.5 million, or 3.3% of net sales, in the third quarter of 2012. The decrease was due to $6.3 million of acquisition expense related to the Sunquest acquisition in the prior year quarter, offset in part by higher equity compensation (as a result of higher stock prices) and other compensation related costs in the current year quarter.

Interest expense in the third quarter of 2013 was $24.7 million as compared to $16.5 million in the third quarter of 2012, due to higher average debt balances related to acquisitions, offset in part by lower average interest rates.

Other income in the third quarter of 2013 was $0.4 million as compared to other expense of $1.4 million in the third quarter of 2012.  Other income and expense in both 2013 and 2012 were due primarily to foreign exchange losses and gains at our non-U.S. based companies.

Our third quarter effective income tax rate was 30.1% as compared to the prior year rate of 29.0%. The increase is due to increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.

At September 30, 2013, the functional currencies of our European subsidiaries were stronger and the Canadian dollar was weaker against the U.S. dollar compared to currency exchange rates at June 30, 2013. The currency changes resulted in a pre-tax increase of $33.7 million in the foreign exchange component of comprehensive earnings for the current year quarter. Approximately $17 million of the total adjustment is related to goodwill and does not directly affect our expected future cash flows. During the quarter ended September 30, 2013 the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to the quarter ended September 30, 2012.  The difference between the operating profits for these companies for the third quarter of 2013 compared to the prior year quarter, translated into U.S. dollars, was approximately 1%.

Net orders were $838.3 million for the third quarter of 2013, $118.5 million higher than the third quarter 2012 net order intake of $719.7 million.  Organic growth contributed 7%, and acquisitions contributed 10% to the current quarter orders. Overall, our order backlog at September 30, 2013 was up 7% as compared to September 30, 2012.

	Net orders booked for thethree months ended September 30,				Order backlog as of September 30,
	2013		2012		2013		2012
Industrial Technology	$	197,549	$	191,955	$	131,768	$	143,808
Energy Systems & Controls		148,922		147,304		120,415		118,510
Medical & Scientific Imaging		262,320		177,528		276,926		243,749
RF Technology		229,484		202,959		515,683		472,342
	$	838,275	$	719,746	$	1,044,792	$	978,409

Nine months ended September 30, 2013 compared to nine months ended September 30, 2012

Net sales for the nine months ended September 30, 2013 were $2.3 billion as compared to $2.2 billion in the prior year nine month period, an increase of 8%.  The increase was due primarily to acquisitions, offset in part by a small negative impact from foreign currency.

In our Industrial Technology segment, net sales decreased by 3% to $580.5 million in the first nine months of 2013 as compared to $598.1 million in the first nine months of 2012.  The decrease was due primarily to the loss of a customer at our water metering business and lower sales at our materials testing business.  Gross margins were 51.1% for the first nine months of 2013 as compared to 50.8% in the first nine months of 2012 due primarily to product mix.  SG&A expenses as a percentage of net sales were 22.8%, as compared to 20.7% in the prior year nine month period, due primarily to a $9.1 million pretax charge for warranty expense at one of our subsidiaries, Hansen Technologies, to provide its customers with replacements for refrigeration valves that included a vendor-supplied component that did not meet Roper quality standards.  The resulting operating profit margins were 28.3% in the first nine months of 2013 as compared to 30.1% in the first nine months of 2012.

Net sales in our Energy Systems & Controls segment decreased by 1% to $456.0 million during the first nine months of 2013 compared to $461.5 million in the first nine months of 2012, due to lower sales of pressure sensors for industrial applications and non-destructive testing systems for nuclear plants which was offset in part by increased demand for control systems for oil and gas applications.  Gross margins were 56.2% in the first nine months of 2013, compared to 55.1% in the first nine months of 2012, due to product mix. SG&A expenses as a percentage of net sales were 30.3% as compared to 29.4% in the prior year nine month period due to product mix. Operating margins were 26.0% in the first nine months of 2013 as compared to 25.7% in first nine months of 2012.

In our Medical & Scientific Imaging segment, net sales increased 33% to $645.7 million in the first nine months of 2013 as compared to $486.2 million in the first nine months of 2012.  The change was comprised of a 35% increase from acquisitions, negative organic growth of 2%, and a small negative foreign exchange impact.  We experienced continued growth in our medical businesses, which was more than offset by weakness in camera sales into research markets.  Gross margins increased to 68.3% in the first nine months of 2013 from 64.7% in the first nine months of 2012, due to the higher gross margin profile of our acquired businesses. SG&A expenses as a percentage of net sales were 40.5% in the nine month period ended September 30, 2013 as compared to 38.9% in the nine month period ended September 30, 2012 due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements).  Operating margins were 27.8% in the first nine months of 2013 as compared to 25.8% in the first nine months of 2012.

In our RF Technology segment, net sales were $666.7 million in the first nine months of 2013 compared to $637.8 million in the first nine months of 2012, an increase of 5%. The increase was due primarily to growth in our toll and traffic, university card systems and security solutions businesses. Gross margins in the first nine months of 2013 were 53.4% as compared to 52.2% in the prior year nine month period due to product mix.  SG&A expenses as a percentage of net sales in the first nine months of 2013 were 25.8% as compared to 26.0% in the first nine months of 2012.  Operating profit margins were 27.6% in 2013 as compared to 26.1% in 2012.

Corporate expenses increased by $3.3 million to $61.7 million, or 2.6% of net sales, in the first nine months of 2013 as compared to $58.4 million, or 2.7% of net sales, in the first nine months of 2012. The increase was due to higher equity compensation (as a result of higher stock prices) offset in part by decreased acquisition costs over the prior year nine month period.

Interest expense was $67.9 million for the first nine months of 2013 as compared to $47.0 million for the first nine months of 2012, due to higher average debt balances related to acquisitions, offset in part by lower average interest rates.

Other income in the nine months ended September 30, 2013 was $0.4 million, due primarily to a one-time pretax gain related to a legal settlement offset by foreign exchange losses at our non-U.S. based companies, as compared to other expense of $2.4 million in the nine months ended September 30, 2012, due primarily to foreign exchange losses at our non-U.S. based companies.

Income taxes were 27.9% of pretax earnings in the first nine months of 2013 as compared to 29.5% of pretax earnings in the first nine months of 2012.  The reduction was due to $6 million in discrete tax benefits related to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), as well as a $6 million benefit from the adjustment of tax balances which were immaterial to any covered period, offset in part by increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.

At September 30, 2013, the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to currency exchange rates at December 31, 2012. The currency changes resulted in a pretax decrease of $11 million in the foreign exchange component of comprehensive earnings for the nine months ended September 30, 2013, $7 million of which was related to goodwill.  Goodwill changes from currency exchange rate changes do not directly affect our reported earnings or cash flows.  During the nine months ended September 30, 2013 the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to the nine months ended September 30, 2012.  The difference between the operating profits for these companies for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, translated into U.S. dollars, was approximately 1%.

Financial Condition, Liquidity and Capital Resources

Selected cash flows for the three and nine month periods ended September 30, 2013 and 2012 were as follows (in millions):

	Three months ended September 30,						Nine months ended September 30,
	2013			2012			2013			2012
Cash provided by/(used in):
Operating activities	$	255.8		$	205.4		$	566.8		$	466.2
Investing activities		(18.6	)		(1,417.3	)		(1,046.7	)		(1,474.1	)
Financing activities		(161.4	)		1,039.6			569.5			1,020.0

Operating activities - Net cash provided by operating activities in the third quarter of 2013 was $50.3 million higher than the third quarter of 2012, due primarily to improved receivables collection and increased earnings net of intangible amortization related to acquisitions.   In the nine month period ending September 30, 2013, operating cash flow increased $100.6 million over the prior year nine month period due to improved receivables collection and increased earnings net of intangible amortization related to acquisitions.

Investing activities - Cash used in investing activities during the three and nine month periods ended September 30, 2013 and 2012 was primarily for business acquisitions and capital expenditures.

Financing activities - Cash used in financing activities in the third quarter of 2013 was for the repayment of our $500 million of senior notes which matured on August 15, 2013, offset in part by revolver borrowings used to repay the notes.  Cash provided by financing activities in the third quarter of 2012 was for revolver borrowings offset partially by dividends and principal debt payments.

Cash provided by financing activities in the nine month period ended September 30, 2013 was primarily for principal debt borrowings for acquisitions, offset in part by principal debt payments and dividends.  Cash provided by financing activities in the nine month period ended September 30, 2012 was from revolver borrowings offset partially by dividends and principal debt payments.

Total debt at September 30, 2013 consisted of the following (amounts in thousands):

$400 million senior notes due 2017	$	400,000
$800 million senior notes due 2018		800,000
$500 million senior notes due 2019		500,000
$500 million senior notes due 2022		500,000
Senior Subordinated Convertible Notes		9,770
Revolving Facility		390,000
Other		6,087
Total debt		2,605,857
Less current portion		12,250
Long-term debt	$	2,593,607

The interest rate on borrowings under our $1.5 billion credit facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At September 30, 2013, there were $390 million of outstanding borrowings under the facility.  At September 30, 2013, we had $6.1 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses and $40 million of outstanding letters of credit.

On June 6, 2013, we completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due 2018. See Note 8 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the notes.

The cash and short-term investments at our foreign subsidiaries at September 30, 2013 totaled $357 million.  Repatriation of these funds under current regulatory and tax law for use in domestic operations would expose us to additional taxes.  We expect existing cash and cash equivalents, cash generated by our U.S. operations, our unsecured credit facility, as well as our expected ability to access the capital markets, will be sufficient to fund operating requirements in the U.S. for the foreseeable future.

We were in compliance with all debt covenants related to our credit facilities throughout the nine months ended September 30, 2013.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $307.3 million at September 30, 2013 compared to $307.8 million at December 31, 2012, reflecting decreased working capital due primarily to increases in deferred revenue and MHA revenue-share obligations offset in part by increases in deferred tax assets related primarily to the MHA acquisition.

Total debt was $2.61 billion at September 30, 2013 compared to $2.02 billion at December 31, 2012 due to borrowings to fund acquisitions offset in part by the use of operating cash flows to reduce outstanding debt.  Our leverage is shown in the following table (in thousands):

	September 30, 2013			December 31, 2012
Total debt	$	2,605,857		$	2,022,122
Cash		(459,980	)		(370,590	)
Net debt		2,145,877			1,651,532
Stockholders' equity		4,062,813			3,687,726
Total net capital	$	6,208,690		$	5,339,258
Net debt / Total net capital		34.6	%		30.9	%

At September 30, 2013, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Capital expenditures of $33.3 million and $29.2 million were incurred during the nine months ended September 30, 2013 and 2012, respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.

Outlook

Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factor's effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also will similarly disrupt the economy.

We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.

We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of outstanding debt. However, the rate at which we can reduce our debt during 2013 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See "Item 7A - Quantitative and Qualitative Disclosures about Market Risk," in our 2012 Annual Report on Form 10-K. There were no material changes during the three or nine month periods ended September 30, 2013.

ITEM 4.  CONTROLS AND PROCEDURES

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report ("Evaluation Date"). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal controls during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Part II.OTHER INFORMATION

Item 1.Legal Proceedings

Information pertaining to legal proceedings can be found in Note 10 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this report, and is incorporated by reference herein.

Item 1A.Risk Factors

For information regarding factors that could affect our results of operations, financial condition and liquidity, see the risk factors discussion in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012 as filed on February 25, 2013 with the SEC. See also, "Information about Forward-Looking Statements" included in Part I, Item 2 of this Quarterly Report on Form 10-Q.

Item 6.Exhibits

31.1	Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
31.2	Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
32.1	Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
101.INS	XBRL Instance Document, furnished herewith.
101.SCH	XBRL Taxonomy Extension Schema Document, furnished herewith.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Roper Industries, Inc.

/s/ Brian D. Jellison	Chairman of the Board, President,	November 8, 2013
Brian D. Jellison	and Chief Executive Officer
	(Principal Executive Officer)

/s/ John Humphrey	Chief Financial Officer and	November 8, 2013
John Humphrey	Executive Vice President
	(Principal Financial Officer)

/s/ Paul J. Soni	Vice President and Controller	November 8, 2013
Paul J. Soni	(Principal Accounting Officer)

EXHIBIT INDEX

TO REPORT ON FORM 10-Q

NumberExhibit

31.1	Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
31.2	Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
32.1	Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
101.INS	XBRL Instance Document, furnished herewith.
101.SCH	XBRL Taxonomy Extension Schema Document, furnished herewith.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.

EX-31.1

Exhibit 31.1

I, Brian D. Jellison, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Roper Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 8, 2013

/s/ Brian D. Jellison

Brian D. Jellison

Chairman, President and

Chief Executive Officer

EX-31.2

Exhibit 31.2

I, John Humphrey, certify that:

1I have reviewed this Quarterly Report on Form 10-Q of Roper Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 8, 2013

/s/ John Humphrey

John Humphrey

Executive Vice President and

Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Roper Industries, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Brian D. Jellison, Chief Executive Officer of the Company, and John Humphrey, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 8, 2013	/s/ Brian D. Jellison
	Brian D. Jellison
	Chairman, President and Chief Executive Officer
	(Principal Executive Officer)
	/s/ John Humphrey
	John Humphrey
	Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)

This certificate is being made for the exclusive purpose of compliance of the Company with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be disclosed, distributed or used by any person or for any reason other than specifically required by law.

XML

Business Segments

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Business Segments

11. Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three months endedSeptember 30,						Nine months endedSeptember 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	200,684	$	199,008	0.8	%	$	580,466	$	598,088	(2.9	)%
Energy Systems & Controls		155,058		158,169	(2.0	)		456,031		461,508	(1.2	)
Medical & Scientific Imaging		237,338		172,475	37.6			645,739		486,207	32.8
RF Technology		234,730		217,989	7.7			666,719		637,776	4.5
Total	$	827,810	$	747,641	10.7	%	$	2,348,955	$	2,183,579	7.6	%
Gross profit:
Industrial Technology	$	101,259	$	102,569	(1.3	)%	$	296,414	$	304,002	(2.5	)%
Energy Systems & Controls		88,104		87,782	0.4			256,431		254,325	0.8
Medical & Scientific Imaging		167,433		112,013	49.5			440,718		314,411	40.2
RF Technology		125,829		114,191	10.2			356,145		332,618	7.1
Total	$	482,625	$	416,555	15.9	%	$	1,349,708	$	1,205,356	12.0	%
Operating profit*:
Industrial Technology	$	60,753	$	60,628	0.2	%	$	164,278	$	180,211	(8.8	)%
Energy Systems & Controls		41,076		42,890	(4.2	)		118,432		118,749	(0.3	)
Medical & Scientific Imaging		71,968		46,190	55.8			179,433		125,231	43.3
RF Technology		66,469		58,002	14.6			183,828		166,516	10.4
Total	$	240,266	$	207,710	15.7	%	$	645,971	$	590,707	9.4	%
Long-lived assets:
Industrial Technology	$	49,055	$	42,970
Energy Systems & Controls		19,501		19,016
Medical & Scientific Imaging		43,105		44,784
RF Technology		28,360		29,230
Total	$	140,021	$	136,000

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,917 and $24,453 for the three months ended September 30, 2013 and 2012, respectively, and $61,699 and $58,362 for the nine months ended September 30, 2013 and 2012, respectively.

XML

Condensed Consolidated Balance Sheets (unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Assets
Cash and cash equivalents	$ 459,980	$ 370,590
Accounts receivable, net	505,284	526,408
Inventories, net	204,722	190,867
Deferred taxes	88,421	41,992
Unbilled receivables	85,375	72,193
Other current assets	45,417	43,492
Total current assets	1,389,199	1,245,542
Property, plant and equipment, net	117,785	110,397
Goodwill	4,541,772	3,868,857
Other intangible assets, net	2,051,685	1,698,867
Deferred taxes	68,048	78,644
Other assets	77,086	68,797
Total assets	8,245,575	7,071,104
Liabilities and Stockholders' Equity
Accounts payable	142,987	138,340
Accrued Compensation	100,901	110,724
Deferred Revenue, Current	212,275	185,912
Accrued liabilities	153,293	128,351
Deferred taxes	12,431	3,868
Current portion of long-term debt, net	12,250	519,015
Total current liabilities	634,137	1,086,210
Long-term debt, net of current portion	2,593,607	1,503,107
Deferred taxes	862,986	707,278
Other liabilities	92,032	86,783
Total liabilities	4,182,762	3,383,378
Common stock	1,013	1,006
Additional paid-in capital	1,219,648	1,158,001
Retained earnings	2,813,356	2,489,858
Accumulated other comprehensive earnings	48,318	58,537
Treasury stock	(19,522)	(19,676)
Total stockholders' equity	4,062,813	3,687,726
Total liabilities and stockholders' equity	$ 8,245,575	$ 7,071,104

XML

Business Acquisitions

9 Months Ended

Sep. 30, 2013

Business Acquisitions [Abstract]

Business Acquisitions [Text Block]

4. Business Acquisitions

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction.  MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform.  MHA is reported in the Medical & Scientific Imaging segment.

During the nine month period ended September 30, 2013, the Company expensed transaction costs of $2.5 million related to the acquisition as corporate general and administrative expenses, as incurred.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.  The allocation of the purchase price is considered preliminary pending tax-related adjustments.  Pro forma data has not been provided as the acquisition of MHA was not material to the Company's operations.

Current assets	$         59,813
Identifiable intangibles	465,500
Goodwill	680,732
Other assets	5,798
Total assets acquired	1,211,843
Current liabilities	(24,717	)
Long-term deferred tax liability	(165,052	)
Other liabilities	(6,524	)
Net assets acquired	$    1,015,550

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable at the date of acquisition. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue-share obligation owed to customers that generated the administrative fees.  Both of these fair value adjustments were fully amortized as of September 30, 2013.

The majority of the goodwill is not expected to be deductible for tax purposes.  Of the $466 million of intangible assets acquired, $28 million was assigned to trade names that are not subject to amortization. The remaining $438 million of acquired intangible assets have a weighted-average useful life of approximately 20 years. The intangible assets that make up that amount include customer relationships of $433 million (20 year weighted-average useful life) and technology of $5 million (3 year weighted-average useful life).

On August 22, 2012, Roper acquired 100% of the shares of Sunquest Information Systems, Inc. ("Sunquest").  Roper's results for the quarter ended September 30, 2012 included results from Sunquest between August 22, 2012 and September 30, 2012.  In that period, Sunquest contributed $21.0 million in revenue and $0.2 million of earnings (inclusive of deal-related costs) to Roper's results.  The following unaudited pro forma summary presents consolidated information as if the acquisition of Sunquest had occurred on January 1, 2011.  This supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition of Sunquest been completed on January 1, 2011, nor is it indicative of any future results. Amounts shown are in thousands, except per share data:

	Three months ended September 30, 2012		Nine months ended September 30, 2012
Sales	$	780,278	$	2,320,497
Net income		128,226		380,046
Earnings per share, basic		1.31		3.90
Earnings per share, diluted		1.29		3.82

Pro forma earnings for the three and nine months ended September 30, 2012 were adjusted by $41.3 million and $50.6 million, respectively, for non-recurring acquisition and other costs as well as recurring changes in amortization, interest expense and taxes related to the acquisition.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]

Roper's debt at September 30, 2013 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million senior notes due 2017	$  398
$800 million senior notes due 2018	786
$500 million senior notes due 2019	583
$500 million senior notes due 2022	468

XML

Earnings Per Share (Policies)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Earnings Per Share Policy

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

XML

Earnings Per Share (Details) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted
Basic shares outstanding	99,207	97,876	99,058	97,460
Effect of potential common stock
Common stock awards	905	1,017	894	1,077
Senior subordinated convertible notes	190	864	200	1,006
Diluted shares outstanding	100,302	99,757	100,152	99,543
Antidilutive stock options	551,850	540,266	601,350	589,666

XML

Business Segments (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Sales and operating profit by business segment Table

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three months endedSeptember 30,						Nine months endedSeptember 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	200,684	$	199,008	0.8	%	$	580,466	$	598,088	(2.9	)%
Energy Systems & Controls		155,058		158,169	(2.0	)		456,031		461,508	(1.2	)
Medical & Scientific Imaging		237,338		172,475	37.6			645,739		486,207	32.8
RF Technology		234,730		217,989	7.7			666,719		637,776	4.5
Total	$	827,810	$	747,641	10.7	%	$	2,348,955	$	2,183,579	7.6	%
Gross profit:
Industrial Technology	$	101,259	$	102,569	(1.3	)%	$	296,414	$	304,002	(2.5	)%
Energy Systems & Controls		88,104		87,782	0.4			256,431		254,325	0.8
Medical & Scientific Imaging		167,433		112,013	49.5			440,718		314,411	40.2
RF Technology		125,829		114,191	10.2			356,145		332,618	7.1
Total	$	482,625	$	416,555	15.9	%	$	1,349,708	$	1,205,356	12.0	%
Operating profit*:
Industrial Technology	$	60,753	$	60,628	0.2	%	$	164,278	$	180,211	(8.8	)%
Energy Systems & Controls		41,076		42,890	(4.2	)		118,432		118,749	(0.3	)
Medical & Scientific Imaging		71,968		46,190	55.8			179,433		125,231	43.3
RF Technology		66,469		58,002	14.6			183,828		166,516	10.4
Total	$	240,266	$	207,710	15.7	%	$	645,971	$	590,707	9.4	%
Long-lived assets:
Industrial Technology	$	49,055	$	42,970
Energy Systems & Controls		19,501		19,016
Medical & Scientific Imaging		43,105		44,784
RF Technology		28,360		29,230
Total	$	140,021	$	136,000

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,917 and $24,453 for the three months ended September 30, 2013 and 2012, respectively, and $61,699 and $58,362 for the nine months ended September 30, 2013 and 2012, respectively.

XML

Fair Value of Financial Instruments (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013
Convertible Notes
Short-term Debt [Line Items]
ST Debt Instrument, Face Amount	$ 10
Fair Value of Debt Instrument	10
Senior notes due 2017
Debt Instrument [Line Items]
Face Value of Debt Instrument	400
Long-term Debt, Fair Value	398
Senior Notes due 2018
Debt Instrument [Line Items]
Face Value of Debt Instrument	800
Long-term Debt, Fair Value	786
Senior Notes due 2019
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Long-term Debt, Fair Value	583
Senior notes due 2022
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Long-term Debt, Fair Value	$ 468

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Goodwill [Line Items]
Balances	$ 3,868,857
Goodwill acquired	680,732
Goodwill, Other Changes	(1,178)
Currency translation adjustments	(6,639)
Balances	4,541,772
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	2,702,402		2,241,957
Accumulated amortization	(650,717)		(543,090)
Net book value	2,051,685		1,698,867
Amortization expense of other intangible assets	108,223	79,335
Assets subject to amortization | Customer related intangibles
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	1,939,270		1,509,339
Accumulated amortization	(456,068)		(379,535)
Net book value	1,483,202		1,129,804
Assets subject to amortization | Unpatented technology
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	212,049		198,609
Accumulated amortization	(116,355)		(97,487)
Net book value	95,694		101,122
Assets subject to amortization | Software
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	160,496		160,520
Accumulated amortization	(54,777)		(44,256)
Net book value	105,719		116,264
Assets subject to amortization | Patents and other protective rights
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	30,390		40,399
Accumulated amortization	(22,017)		(20,312)
Net book value	8,373		20,087
Assets subject to amortization | Trade secrets
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	1,500		1,500
Accumulated amortization	(1,500)		(1,500)
Net book value	0		0
Assets not subject to amortization | Trade names
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	358,697		331,590
Accumulated amortization	0		0
Net book value	358,697		331,590
Industrial Technology
Goodwill [Line Items]
Balances	421,755
Goodwill acquired	0
Goodwill, Other Changes	0
Currency translation adjustments	1,929
Balances	423,684
Energy Systems And Controls
Goodwill [Line Items]
Balances	404,057
Goodwill acquired	0
Goodwill, Other Changes	2,660
Currency translation adjustments	(215)
Balances	406,502
Medical And Scientific Imaging
Goodwill [Line Items]
Balances	1,772,402
Goodwill acquired	680,732
Goodwill, Other Changes	(4,283)
Currency translation adjustments	(7,084)
Balances	2,441,767
RF Technology
Goodwill [Line Items]
Balances	1,270,643
Goodwill acquired	0
Goodwill, Other Changes	445
Currency translation adjustments	(1,269)
Balances	$ 1,269,819

XML

Contingencies (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Warranty Accrual Activity Table

Balance at December 31, 2012	$	9,755
Additions charged to costs and expenses*		17,659
Deductions		(11,251	)
Other		(168)
Balance at September 30, 2013	$	15,995

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) (USD $) In Thousands	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive earnings	Treasury stock	Total
Beginning Balance at Dec. 31, 2012	$ 1,006	$ 1,158,001	$ 2,489,858	$ 58,537	$ (19,676)	$ 3,687,726
Net earnings	0	0	372,590	0	0	372,590
Stock option exercises	4	20,446	0	0	0	20,450
Treasury stock sold	0	1,679	0	0	154	1,833
Currency translation adjustments, net of tax	0	0	0	(10,219)	0	(10,219)
Stock based compensation	0	40,201	0	0	0	40,201
Restricted stock activity	3	(3,598)	0	0	0	(3,595)
Stock option tax benefit, net of shortfalls	0	7,632	0	0	0	7,632
Conversion of senior subordinated convertible notes		(4,713)	0	0	0	(4,713)
Dividends declared	0	0	(49,092)	0	0	(49,092)
Ending Balance at Sep. 30, 2013	$ 1,013	$ 1,219,648	$ 2,813,356	$ 48,318	$ (19,522)	$ 4,062,813

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Recent Accounting Pronouncements

2. Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In July 2012, the FASB issued an amendment to accounting rules related to the testing of indefinite-lived intangibles.  The new accounting rules permit an entity to first assess qualitative factors to determine if it is more likely than not that an indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test prescribed under current accounting rules.   Roper adopted this guidance on January 1, 2013.  The guidance did not have an impact on the Company's results of operations, financial position or cash flows.

XML

Stock Based Compensation

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Stock-Based Compensation

5. Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan (the "Plan") is a stock based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. The common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock based compensation expense (in thousands):

	Three months ended September 30,				Nine months endedSeptember 30,
	2013		2012		2013		2012
Stock based compensation	$	13,756	$	10,439	$	40,040	$	30,143
Tax effect recognized in net income		4,814		3,654		14,014		10,550
Windfall tax benefit, net		2,075		9,009		7,632		19,975

Stock Options - In the nine month period ended September 30, 2013, 560,350 options were granted with a weighted average fair value of $36.87 per option. During the same period in 2012, 531,100 options were granted with a weighted average fair value of $30.19 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data, among other factors, is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year periods using the Black-Scholes option-pricing model:

	Nine months ended September 30,
	2013	2012
Fair value per share ($)	36.87	30.19
Risk-free interest rate (%)	0.80	0.77
Expected option life (years)	5.19	5.24
Expected volatility (%)	36.20	36.51
Expected dividend yield (%)	0.57	0.58

Cash received from option exercises for the nine months ended September 30, 2013 and 2012 was $20.5 million and $40.1 million, respectively.

Restricted Stock Awards - During the nine months ended September 30, 2013, 357,240 restricted stock awards were granted with a weighted average fair value of $116.76 per restricted share. During the same period in 2012, 358,807 awards were granted with a weighted average fair value of $95.10 per restricted share. All grants were issued at grant date fair value.

During the nine months ended September 30, 2013, 123,762 restricted awards vested with a weighted average grant date fair value of $63.65 per restricted share, at a weighted average vest date fair value of $120.92 per restricted share.

Employee Stock Purchase Plan - During the nine month periods ended September 30, 2013 and 2012, participants of the employee stock purchase plan purchased 15,458 and 17,410 shares, respectively, of Roper's common stock for total consideration of $1.8 million and $1.6 million, respectively. All shares were purchased from Roper's treasury shares.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Earnings Per Share

3. Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Basic shares outstanding		99,207		97,876		99,058		97,460
Effect of potential common stock:
Common stock awards		905		1,017		894		1,077
Senior subordinated convertible notes		190		864		200		1,006
Diluted shares outstanding		100,302		99,757		100,152		99,543

For the three and nine month periods ended September 30, 2013 there were 551,850 and 601,350 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive; this compares to 540,266 and 589,666 outstanding stock options, respectively, that would have been antidilutive for the three and nine month periods ended September 30, 2012.

XML

Business Acquisitions (Details) (USD $)			9 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013 Mha Acquisition [Member]	May 01, 2013 Mha Acquisition [Member]	Sep. 30, 2013 Mha Acquisition [Member] Customer Relationships [Member]	Sep. 30, 2013 Mha Acquisition [Member] Unpatented Technology [Member]	Sep. 30, 2012 Sunquest Acquisition [Member]	Sep. 30, 2012 Sunquest Acquisition [Member]
Business Acquisition [Line Items]
Business Acquisition, Effective Date of Acquisition			May 01, 2013					Aug. 22, 2012
Payments to Acquire Businesses, Gross			$ 1,000,000,000
Business Acquisition, Percentage of Voting Interests Acquired			100.00%				100.00%	100.00%
Name of Acquired Entity			Managed Health Care Associates, Inc. ("MHA")					Sunquest Information Systems, Inc. ("Sunquest")
Description of Acquired Entity			MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform. MHA is reported in the Medical & Scientific Imaging segment.
Reason for Business Combination			The acquisition of MHA complements and expands the Company's medical platform.
Cost of Acquired Entity Transaction Costs			2,500,000
Business Combination, Admin Fee Receivables [Abstract]
Business Combination, Acquired Receivables, Description			The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable at the date of acquisition.
Business Combination, Liability Related to Acquired Receivables, Description			The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue-share obligation owed to customers that generated the administrative fees.
Business Combination, Acquired Receivables, Fair Value			0	35,000,000
Business Combination, Liability Related to Acquired Receivables, Fair Value			0	8,600,000
Business Combination, Acquired Receivables, Fair Value Net of Liability			0
Indefinite-lived Intangible Assets Acquired			28,000,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other			59,813,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total			465,500,000
Goodwill	4,541,772,000	3,868,857,000	680,732,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets			5,798,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total			1,211,843,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other			24,717,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent			165,052,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other			6,524,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net, Total			1,015,550,000
Business Acquisition, Pro Forma Revenue							780,278,000	2,320,497,000
Business Acquisition, Pro Forma Net Income (Loss)							128,226,000	380,046,000
Business Acquisition, Pro Forma Earnings Per Share, Basic							$ 1.31	$ 3.90
Business Acquisition, Pro Forma Earnings Per Share, Diluted							$ 1.29	$ 3.82
Business Acquisition, Pro Forma Information, Description								Pro forma earnings for the three and nine months ended September 30, 2012 were adjusted by $41.3 million and $50.6 million, respectively, for non-recurring acquisition and other costs as well as recurring changes in amortization, interest expense and taxes related to the acquisition.
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired					$ 433,000,000	$ 5,000,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					20 years	3 years

XML

Debt, Extinguishment (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Extinguishment of Debt [Line Items]
Stated Interest Rate Percentage - Debt Instruments	3.75%
Maturity Date - Debt Instrument	Jan. 15, 2034
First Conversion Date	Jan. 15, 2009
Number of Notes Converted	4,471
Cash Payments for Debt Conversions (in millions)	$ 7.1
Deferred Tax Liability (in millions)	0.4
Per Note Conversion Price	$ 471
Excess above Principal Note Amount (in millions)	$ 25
If converted, issuance of common stock shares	190,306

XML

Condensed Consolidated Statements of Comprehensive Income (unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]
Net earnings	$ 136,323	$ 116,708	$ 372,590	$ 339,830
Comprehensive income, net of tax
Foreign currency translation adjustments	31,902	36,395	(10,219)	22,348
Total other comprehensive income/(loss), net of tax	31,902	36,395	(10,219)	22,348
Comprehensive income	$ 168,225	$ 153,103	$ 362,371	$ 362,178

XML

Debt

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Debt

8. Debt

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018.  The notes were issued at 99.791% of their principal amount.  The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility.

The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness.  The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness.  The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.

On August 15, 2013, $500 million of senior notes matured, and were repaid using borrowings from the Company's $1.5 billion revolving credit facility.

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the nine month period ended September 30, 2013, 4,471 notes were converted for $7.1 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.4 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At September 30, 2013, the conversion price on the outstanding notes was $470.55.  If converted at September 30, 2013, the value would exceed the $10 million principal amount of the notes by approximately $25 million and could result in the issuance of 190,306 shares of Roper's common stock.

XML

Condensed Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net earnings	$ 372,590	$ 339,830
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	28,269	28,402
Amortization of intangible assets	111,210	82,398
Amortization of deferred financing costs	2,916	1,750
Non-cash stock compensation	40,040	30,143
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	43,101	6,685
Unbilled receivables	(13,257)	(2,698)
Inventories	(15,202)	(2,985)
Accounts payable and accrued liabilities	13,055	(8,617)
Income taxes	(12,643)	(14,258)
Other, net	(3,306)	5,564
Cash provided by operating activities	566,773	466,214
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(1,014,952)	(1,445,549)
Capital expenditures	(33,349)	(29,236)
Proceeds from sale of assets	1,740	1,196
Other, net	(144)	(542)
Cash used in investing activities	(1,046,705)	(1,474,131)
Cash flows from financing activities:
Proceeds from Issuance of Senior Long-term Debt	800,000	0
Proceeds from (Repayments of) Notes Payable	(500,000)	0
Borrowings/(payments) under revolving line of credit, net	290,000	1,050,000
Principal payments on convertible notes	(2,115)	(26,826)
Cash dividends to stockholders	(32,706)	(40,102)
Stock award tax excess windfall benefit	7,763	19,873
Payments of Debt Issuance Costs	(7,717)	(4,551)
Treasury stock sales	1,833	1,623
Proceeds from stock based compensation, net	16,839	40,105
Cash Premium on Convertible Debt	(5,100)	(19,149)
Other	723	(979)
Cash provided by/(used in) financing activities	569,520	1,019,994
Effect of foreign currency exchange rate changes on cash	(198)	4,931
Net increase/(decrease) in cash and cash equivalents	89,390	17,008
Cash and cash equivalents, end of period	370,590	338,101
Cash and cash equivalents, end of period	$ 459,980	$ 355,109

XML

Condensed Consolidated Statements of Earnings (unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Condensed Consolidated Statements of Earnings
Net sales	$ 827,810	$ 747,641	$ 2,348,955	$ 2,183,579
Cost of sales	345,185	331,086	999,247	978,223
Gross profit	482,625	416,555	1,349,708	1,205,356
Selling, general and administrative expenses	263,276	233,298	765,436	673,011
Income from operations	219,349	183,257	584,272	532,345
Interest expense	24,705	16,456	67,924	47,016
Loss on extinguishment of debt	0	1,043	0	1,043
Other income/(expense)	409	(1,380)	453	(2,444)
Earnings before income taxes	195,053	164,378	516,801	481,842
Income taxes	58,730	47,670	144,211	142,012
Net earnings	$ 136,323	$ 116,708	$ 372,590	$ 339,830
Earnings per share:
Basic	$ 1.37	$ 1.19	$ 3.76	$ 3.49
Diluted	$ 1.36	$ 1.17	$ 3.72	$ 3.41
Weighted average common shares outstanding:
Basic	99,207	97,876	99,058	97,460
Diluted	100,302	99,757	100,152	99,543
Dividends declared per common share	$ 0.1650	$ 0.1375	$ 0.4950	$ 0.4125

XML

Stock Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Notes to Financial Statements [Abstract]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan	10.00%		10.00%
Discount on the average closing price for the employee stock purchase plan			5.00%
Stock Based Compensation Expense Table
Stock based compensation	$ 13,756,000	$ 10,439,000	$ 40,040,000	$ 30,143,000
Tax effect recognized in net income	4,814,000	3,654,000	14,014,000	10,550,000
Windfall tax benefit/(shortfall), net	2,075,000	9,009,000	7,632,000	19,975,000
Employee stock options granted during the period			560,350	531,100
Weighted average assumptions used to value option grants Table
Fair value per share ($)			$ 36.87	$ 30.19
Risk-free interest rate (%)			0.80%	0.77%
Expected option life (years)			5 years 3 months 9 days	5 years 3 months 27 days
Expected volatility (%)			36.20%	36.51%
Expected dividend yield (%)			0.57%	0.58%
Cash received from exercise of options			20,500,000	40,100,000
Restricted stock awards granted during period			357,240	358,807
Weighted average fair value per share of restricted stock awards granted during the period			$ 116.76	$ 95.1
Restricted stock awards vested during period			123,762
Weighted average grant date fair value per share			$ 63.65
Weighted average vest date fair value per share			$ 120.92
Shares of stock purchased during the period by participants in the employee stock purchase plan			15,458	17,410
Amount paid for stock purchased during the period by participants in the employee stock purchase plan			$ 1,800,000	$ 1,600,000

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Goodwill

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology		Energy Systems & Controls			Medical & Scientific Imaging			RFTechnology			Total
Balances at December 31, 2012	$	421,755	$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-		-			680,732			-			680,732
Other		-		2,660			(4,283	)		445			(1,178	)
Currency translation adjustments		1,929		(215	)		(7,084	)		(1,269	)		(6,639	)
Balances at September 30, 2013	$	423,684	$	406,502		$	2,441,767		$	1,269,819		$	4,541,772

Other Intangible Assets

Other intangible assets are comprised of (in thousands):

	Cost		Accumulatedamortization			Net bookvalue
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,939,270	$	(456,068	)	$	1,483,202
Unpatented technology		212,049		(116,355	)		95,694
Software		160,496		(54,777	)		105,719
Patents and other protective rights		30,390		(22,017	)		8,373
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		358,697		-			358,697
Balances at September 30, 2013	$	2,702,402	$	(650,717	)	$	2,051,685

XML

Contingencies (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Notes to Financial Statements [Abstract]
Standard Product Warranty Description	Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.
Warranty Accrual Activity Table
Balance	$ 9,755
Additions charged to costs and expenses	17,659
Deductions	(11,251)
Other	(168)
Balance	$ 15,995

XML

Business Segments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Net sales	$ 827,810	$ 747,641	$ 2,348,955	$ 2,183,579
Percent change in Net Sales	0.107		0.076
Gross Profit	482,625	416,555	1,349,708	1,205,356
Percent change in Gross Profit	0.159		0.12
Operating profit	240,266	207,710	645,971	590,707
Percent change in Operating Profit	0.157		0.094
Long-Lived assets	140,021	136,000	140,021	136,000
Unallocated corporate general and administrative expenses	20,917	24,453	61,699	58,362
Industrial Technology
Segment Reporting Information [Line Items]
Net sales	200,684	199,008	580,466	598,088
Percent change in Net Sales	0.008		(0.029)
Gross Profit	101,259	102,569	296,414	304,002
Percent change in Gross Profit	(0.013)		(0.025)
Operating profit	60,753	60,628	164,278	180,211
Percent change in Operating Profit	0.002		(0.088)
Long-Lived assets	49,055	42,970	49,055	42,970
Energy Systems And Controls
Segment Reporting Information [Line Items]
Net sales	155,058	158,169	456,031	461,508
Percent change in Net Sales	(2)		(1.2)
Gross Profit	88,104	87,782	256,431	254,325
Percent change in Gross Profit	0.4		0.8
Operating profit	41,076	42,890	118,432	118,749
Percent change in Operating Profit	(4.2)		(0.3)
Long-Lived assets	19,501	19,016	19,501	19,016
Medical And Scientific Imaging
Segment Reporting Information [Line Items]
Net sales	237,338	172,475	645,739	486,207
Percent change in Net Sales	37.6		32.8
Gross Profit	167,433	112,013	440,718	314,411
Percent change in Gross Profit	49.5		40.2
Operating profit	71,968	46,190	179,433	125,231
Percent change in Operating Profit	55.8		43.3
Long-Lived assets	43,105	44,784	43,105	44,784
RF Technology
Segment Reporting Information [Line Items]
Net sales	234,730	217,989	666,719	637,776
Percent change in Net Sales	7.7		4.5
Gross Profit	125,829	114,191	356,145	332,618
Percent change in Gross Profit	10.2		7.1
Operating profit	66,469	58,002	183,828	166,516
Percent change in Operating Profit	14.6		10.4
Long-Lived assets	$ 28,360	$ 29,230	$ 28,360	$ 29,230

XML

Goodwill and Other Intangible Assets

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

7. Goodwill and Other Intangible Assets

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology		Energy Systems & Controls			Medical & Scientific Imaging			RFTechnology			Total
Balances at December 31, 2012	$	421,755	$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-		-			680,732			-			680,732
Other		-		2,660			(4,283	)		445			(1,178	)
Currency translation adjustments		1,929		(215	)		(7,084	)		(1,269	)		(6,639	)
Balances at September 30, 2013	$	423,684	$	406,502		$	2,441,767		$	1,269,819		$	4,541,772

Other intangible assets are comprised of (in thousands):

	Cost		Accumulatedamortization			Net bookvalue
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,939,270	$	(456,068	)	$	1,483,202
Unpatented technology		212,049		(116,355	)		95,694
Software		160,496		(54,777	)		105,719
Patents and other protective rights		30,390		(22,017	)		8,373
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		358,697		-			358,697
Balances at September 30, 2013	$	2,702,402	$	(650,717	)	$	2,051,685

Amortization expense of other intangible assets was $108,223 and $79,335 during the nine months ended September 30, 2013 and 2012, respectively.

XML

Inventories (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Inventories
Raw materials and supplies	$ 128,809	$ 121,573
Work in process	33,133	29,725
Finished products	88,614	81,536
Inventory reserves	(45,834)	(41,967)
Total Inventory	$ 204,722	$ 190,867

XML

Contingencies

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Contingencies

10. Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. The Company is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the nine months ended September 30, 2013 is presented below (in thousands):

Balance at December 31, 2012	$	9,755
Additions charged to costs and expenses*		17,659
Deductions		(11,251	)
Other		(168)
Balance at September 30, 2013	$	15,995

* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.

XML

Inventories

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Inventories

6. Inventories

The components of inventories at September 30, 2013 and December 31, 2012 were as follows (in thousands)

	September 30,2013			December 31,2012
Raw materials and supplies	$	128,809		$	121,573
Work in process		33,133			29,725
Finished products		88,614			81,536
Inventory reserves		(45,834	)		(41,967	)
	$	204,722		$	190,867

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Basis of Presentation

1. Basis of Presentation

The accompanying condensed consolidated financial statements for the three and nine month periods ended September 30, 2013 and 2012 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2012 financial position data included herein was derived from the audited consolidated financial statements included in the 2012 Annual Report on Form 10-K ("Annual Report") filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.

XML

Debt (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Debt Instrument [Line Items]
Maturity Date	Jan. 15, 2034
Interest Rate (in hundredths)	3.75%
Senior Notes 2013 [Member]
Debt Instrument [Line Items]
Debt Instrument, Description	On August 15, 2013, $500 million of senior notes matured, and were repaid using borrowings from the Company's $1.5 billion revolving credit facility.
Senior Notes due 2018 [Member]
Debt Instrument [Line Items]
Debt Instrument, Description	On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018. The notes were issued at 99.791% of their principal amount. The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility. The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013. Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness. The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness. The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.
Issuance Date	Jun. 06, 2013
Principal amount (in millions)	$ 800
Maturity Date	Oct. 01, 2018
Periodic interest payments	semi-annually in arrears on April 1 and October 1 of each year
Periodic interest payments, start	October 1, 2013
Interest Rate (in hundredths)	2.05%

XML

Stock Based Compensation (Policies)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Stock Based Compensation

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data, among other factors, is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year periods using the Black-Scholes option-pricing model:

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Fair Value of Financial Instruments

9. Fair Value of Financial Instruments

Roper's debt at September 30, 2013 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million senior notes due 2017	$  398
$800 million senior notes due 2018	786
$500 million senior notes due 2019	583
$500 million senior notes due 2022	468

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $10 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

On August 15, 2013, an aggregate notional amount of $500 million in interest rate swaps expired.  The swaps had been designated as fair value hedges which had effectively changed Roper's $500 million senior notes due 2013 with a fixed interest rate of 6.625% to a variable-rate obligation at a weighted average spread of 4.377% plus the 3 month London Interbank Offered Rate ("LIBOR").

XML

Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Stock Based Compensation Expense

The following table provides information regarding the Company's stock based compensation expense (in thousands):

	Three months ended September 30,				Nine months endedSeptember 30,
	2013		2012		2013		2012
Stock based compensation	$	13,756	$	10,439	$	40,040	$	30,143
Tax effect recognized in net income		4,814		3,654		14,014		10,550
Windfall tax benefit, net		2,075		9,009		7,632		19,975

Weighted average assumptions used to value option grants

	Nine months ended September 30,
	2013	2012
Fair value per share ($)	36.87	30.19
Risk-free interest rate (%)	0.80	0.77
Expected option life (years)	5.19	5.24
Expected volatility (%)	36.20	36.51
Expected dividend yield (%)	0.57	0.58

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Basic shares outstanding		99,207		97,876		99,058		97,460
Effect of potential common stock:
Common stock awards		905		1,017		894		1,077
Senior subordinated convertible notes		190		864		200		1,006
Diluted shares outstanding		100,302		99,757		100,152		99,543

XML

Document and Entity Information (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	Roper Industries Inc
Entity Central Index Key	0000882835
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float		$ 9,748,714,212
Entity Common Stock, Shares Outstanding	99,309,540
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013

XML

Business Acquisitions (Tables)

9 Months Ended

Sep. 30, 2013

Business Acquisitions [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Current assets	$         59,813
Identifiable intangibles	465,500
Goodwill	680,732
Other assets	5,798
Total assets acquired	1,211,843
Current liabilities	(24,717	)
Long-term deferred tax liability	(165,052	)
Other liabilities	(6,524	)
Net assets acquired	$    1,015,550

Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table Text Block]

	Three months ended September 30, 2012		Nine months ended September 30, 2012
Sales	$	780,278	$	2,320,497
Net income		128,226		380,046
Earnings per share, basic		1.31		3.90
Earnings per share, diluted		1.29		3.82